Transport of drugs across the blood-brain barrier by nanoparticles.

By Stefanie Wohlfart, S. Gelperina, J. Kreuter. Journal of Controlled Release, 2012

664 citations recorded by the source corpus.

Subfields: Biomaterials, Electronic, Optical and Magnetic Materials, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/5c0bd23a1e5b4496a332de1218ae25d968586d25

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. Elif S. Seven
2. Zhili Peng
3. Elbay Malikmammadov
4. T. E. Tanir
5. R. Leblanc
6. V. Hasırcı
7. Yiqun Zhou
8. A. Kiziltay

In Pharmaceutical Science

1. Elif S. Seven
2. Zhili Peng
3. R. Leblanc
4. Yiqun Zhou

Citations in the corpus

• Current Strategies for Brain Drug Delivery (2018, background): “Extensive reviews can be found elsewhere [29-31].”
• PCL and PCL-based materials in biomedical applications (2018, background): “Therapeutic molecules such as drugs, proteins, and polynucleotides can be loaded into carrier systems in order to improve bioavailability, to increase aqueous solubility and stability, and therefore, control the amount and rate of delivery [34,35], where nano ones can cross biological barriers as bl”
• Crossing the blood‐brain barrier with nanoparticles (2018, background): “To date, drugs delivered with NPs carriers have covered peptides [35], proteins [27], nucleic acid [36], antibodies [37], antiretroviral [38], and anticancer drugs [39].”